Recent Press Releases

Ergomed 2014 Business Update

Expected revenue growth of 14% 40% increase in new contracts won in H2 2014 Guildford, UK – 20 January 2015: Ergomed plc, (LSE: ERGO or 'Ergomed') a profitable UK-based company,...

AMRI RECEIVES NIH CONTRACT AWARD FOR THE FORMULATION DEVELOPMENT AND MANUFACTURE OF PRE-CLINICAL AND CLINICAL DRUG PRODUCT

- 10-YEAR FEDERAL CONTRACT AWARD VALUED AT UP TO $37 MILLION - ALBANY, N.Y., Jan. 19, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it received a 10-year federal contract award from...

Evotec and C4XD enter collaboration to identify pre-clinical development candidates for stress-related addictive disorder programme

* Collaboration leverages the breadth & experience of Evotec's drug discovery infrastructure across chemistry & biology * Efforts will combine the use of C4XD's proprietary NMR...

Catalent & Sanofi To Collaborate On SMARTag™ Antibody-Drug Conjugate Technology With Sanofi's Proprietary Antibodies

Somerset, N.J., USA – Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has...

Clinipace Worldwide Closes on $50 Million M&A War Chest

Clinipace Worldwide Closes on $50 Million M&A War Chest Funding to Fuel Additional Expansion After 40% Year-over-Year Growth in 2014 MORRISVILLE, N.C. (Business Wire) JANUARY 15, 2015 –...

Jamie Macdonald of INC Research Elected 2015 ACRO Chairman

WASHINGTON--The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected Jamie Macdonald, CEO of INC Research (NASDAQ: INCR), as its 2015...

Novella Clinical and the Cardiovascular Research Foundation Collaborate to Provide Comprehensive Clinical Trial Expertise

RESEARCH TRIANGLE PARK, N.C.--Novella Clinical, a Quintiles company (Novella), and the Cardiovascular Research Foundation (CRF) today announced a preferred provider collaboration that will offer a...

Evotec and Padlock Therapeutics Announce Initial Success and Extension of Long-Term Collaboration

Evotec and Padlock Therapeutics Announce Initial Success and Extension of Long-Term Collaboration HAMBURG, Germany, Jan. 7, 2015 (GLOBE NEWSWIRE) -- Evotec AG (EVT.F) (TecDAX) (ISIN:DE0005664809) and...

X-Chem Announces Collaboration with Janssen and Johnson & Johnson Innovation to Advance Novel Candidates to Treat Inflammatory Diseases

--X-Chem to Identify Small Molecule Leads Using its Proprietary Discovery Engine Fueled by a DNA-Encoded Library Exceeding 100 Billion Compounds-- WALTHAM, Mass.--X-Chem, Inc....

AMRI to Acquire Aptuit Drug Product Development and Aseptic Clinical Manufacturing Businesses

ALBANY, N.Y., Jan. 9, 2015 -- AMRI (NASDAQ: AMRI) today announced that it has acquired the outstanding equity interests of Aptuit's Glasgow, UK business and has entered into a definitive...

Evotec and Ohio State to collaborate on novel cancer therapy

*Collaboration leverages the breadth & experience of Evotec's drug discovery infrastructure *Efforts will explore the use of a novel approach, discovered at Ohio State, for targeting mutant...

WuXi Launches Mobile App to Enable Chemistry-on-the-Go

SHANGHAI, Jan. 5, 2015 -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical...

PPD and SNBL Announce Japanese Clinical Development Joint Venture and Additional Collaborations

WILMINGTON, N.C. & TOKYO--Pharmaceutical Product Development, LLC (PPD) and Shin Nippon Biomedical Laboratories Ltd. (SNBL) (TSE:2395) today announced an agreement to form a joint venture that...

WIL Research Partners with Instem for Global Harmonization Project

CONSHOHOCKEN, Pa. -- Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that WIL Research has placed an expanded order for the deployment of...

X-Chem Licenses Cardiovascular Drug Discovery Program to Bayer Pharma AG

--- Second license granted to Bayer within a year--- WALTHAM, Mass.--X-Chem, Inc., a privately held biotechnology company focused on applying its innovative drug discovery capabilities to the...

Achievement of multiple milestones in Evotec's drug discovery alliances

Hamburg, Germany - Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) disclosed today that it achieved multiple milestones in ongoing alliances with its strategic research...

KCR Acquires Project Portfolio from Ukrainian CRO AXIS

WARSAW, Poland--KCR, a European Contract Research Organization (CRO), has recently acquired the whole portfolio of clinical projects from the Ukrainian CRO, AXIS Group Ltd. The acquisition of AXIS...

PPD and ERT Establish Strategic Partnership to Enhance Drug Development

WILMINGTON, N.C., and PHILADELPHIA – Pharmaceutical Product Development, LLC (PPD) and ERT today announced a strategic partnership to facilitate delivery of ERT's comprehensive solutions...

WuXi Opening Offices in Boston and San Francisco

SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries,...

CRO Health Decisions Names Industry Veteran Stephen DeCherney, MD, MPH, Interim CEO

Durham, North Carolina. Health Decisions, Inc., the full-service clinical research organization of choice for forward-looking biopharma and medical device companies, today announced the appointment...